GLYZIMAC MR 60 TABLET

Product Description

GLYZIMAC MR 60 TABLET is a modified-release oral antidiabetic medication containing Gliclazide 60mg, designed for effective and sustained control of Type 2 Diabetes Mellitus. It works by stimulating insulin secretion, improving blood glucose levels, and minimizing the risk of hypoglycemia due to its gradual release mechanism.

Manufactured in WHO-GMP certified facilities, GLYZIMAC MR 60 is ideal for clinics, pharmacies, and B2B distributors seeking a reliable solution for long-term diabetes management.

Key Benefits:

• Gliclazide MR 60mg ensures extended glycemic control

• Reduces blood sugar spikes with once-daily dosing

• Lower risk of weight gain and hypoglycemia

• Manufactured under stringent quality control standards

Applications:

• Used in the management of Type 2 Diabetes

• Recommended for adults with inadequate glycemic control

• Ideal for chronic diabetic care plans

Why Choose GLYZIMAC MR 60 TABLET?

• Proven efficacy in diabetes management protocols

• Strong demand across retail and hospital supply chains

• Suitable for bulk orders, pharma franchises, and institutional buyers